Bad science or medical practices: Who’s really responsible for the Gambia cough syrup deaths?
The unfortunate, and preventable, deaths of around 70 children in the impoverished West African nation are largely attributable to poor drug regulation in India.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Chaos
You may also like
Karan Bajaj, the serial startup hustler, is back
The guy who preyed on your insecurities and sold coding classes for your kids is back to help your loved ones fight cancer. Don’t say we did not warn you.
India’s mad rush for protein products needs a reset
Startups and legacy FMCG players are increasingly launching packaged food rich in protein, but rampant misselling is spoiling the party.
How Bewakoof, once a trendsetter, fell out of favour with young people
Indian youngsters are experimenting with newer D2C brands like never before. Bewakoof’s early success and its 2022 acquisition by retail giant Aditya Birla Fashion should have given it the edge, but the company has been left behind.
